Treatment of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic uremic syndrome (HUS)

Outbreaks of virulent diarrheagenic Escherichia coli- are we in control?

(2012) Dirk Werber et al.   BMC Medicine

Manganese Blocks Intracellular Trafficking of Shiga Toxin and Protects Against Shiga Toxicosis

(2012) S. Mukhopadhyay et al.   SCIENCE

Early Volume Expansion During Diarrhea and Relative Nephroprotection During Subsequent Hemolytic Uremic Syndrome

(2011) Christina A. Hickey   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Serological Response of Shiga Toxin-Producing Escherichia coli Type III Secreted Proteins in Sera from Vaccinated Rabbits, Naturally Infected Cattle, and Humans

(2011) David J. Asper et al.   Clinical and Vaccine Immunology

The 2011 Shiga toxin-producing Escherichia coli O104:H4 German outbreak: a lesson in genomic plasticity

(2011) E. Denamur   CLINICAL MICROBIOLOGY AND INFECTION

In VivoLeukocyte Changes Induced byEscherichia coliSubtilase Cytotoxin

(2011) Hui Wang et al.   INFECTION AND IMMUNITY

B-cell epitope KT-12 of enterohemorrhagic Escherichia coli O157:H7: a novel peptide vaccine candidate

(2011) Cheng-song Wan et al.   MICROBIOLOGY AND IMMUNOLOGY

Eculizumab in Severe Shiga-Toxin–Associated HUS

(2011) Anne-Laure Lapeyraque et al.   NEW ENGLAND JOURNAL OF MEDICINE

Open-Source Genomic Analysis of Shiga-Toxin–ProducingE. coliO104:H4

(2011) Holger Rohde et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antibiotic Treatment of Escherichia coli O157 Infection and the Risk of Hemolytic Uremic Syndrome, Minnesota

(2011) Kirk E. Smith et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide

(2011) Deborah J. Stearns-Kurosawa et al.   PEDIATRIC NEPHROLOGY

Interactions with M Cells and Macrophages as Key Steps in the Pathogenesis of Enterohemorragic Escherichia coli Infections

(2011) Lucie Etienne-Mesmin et al.   PLoS One

Vaccination of attenuated EIS-producing Salmonella induces protective immunity against enterohemorrhagic Escherichia coli in mice

(2011) Jiang Gu et al.   VACCINE

Intragastric immunization of mice with enterohemorrhagic Escherichia coli O157:H7 bacterial ghosts reduces mortality and shedding and induces a Th2-type dominated mixed immune response

(2010) Kun Cai et al.   CANADIAN JOURNAL OF MICROBIOLOGY

Enhanced immunogenicity of a novel Stx2Am-Stx1B fusion protein in a mice model of enterohemorrhagic Escherichia coli O157:H7 infection

(2010) Kun Cai et al.   VACCINE

A DNA Vaccine Encoding the Enterohemorragic Escherichia coli Shiga-Like Toxin 2 A2 and B Subunits Confers Protective Immunity to Shiga Toxin Challenge in the Murine Model

(2009) L. V. Bentancor et al.   Clinical and Vaccine Immunology

Alternative Pathway of Complement in Children with Diarrhea-Associated Hemolytic Uremic Syndrome

(2009) J. M. Thurman et al.   Clinical Journal of the American Society of Nephrology

An Orally Applicable Shiga Toxin Neutralizer Functions in the Intestine To Inhibit the Intracellular Transport of the Toxin

(2009) M. Watanabe-Takahashi et al.   INFECTION AND IMMUNITY

Shiga Toxin Activates Complement and Binds Factor H: Evidence for an Active Role of Complement in Hemolytic Uremic Syndrome

(2009) Dorothea Orth et al.   JOURNAL OF IMMUNOLOGY

Gnotobiotic Piglet Infection Model for Evaluating the Safe Use of Antibiotics againstEscherichia coliO157:H7 Infection

(2009) Quanshun Zhang et al.   JOURNAL OF INFECTIOUS DISEASES

Enterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice

(2009) Jiang Gu et al.   MICROBES AND INFECTION

Management of diarrhea-associated hemolytic uremic syndrome in children

(2008) Kazumoto Iijima et al.   Clinical and Experimental Nephrology

The excretion of F18+E. coli is reduced after oral immunisation of pigs with a FedF and F4 fimbriae conjugate

(2008) P. Tiels et al.   VACCINE